One group indicated that a lower level of CacyBP/SIP was present in the tumor tissue in comparison to the control one and, moreover, reduction in CacyBP/SIP expression was associated with poor prognosis of breast cancer patients [15]. The gene discussed is CACYBP; the disease is breast carcinoma.